Laughing Water Capital on X
Lifecore Biomedical's Series A preferred can PIK rather than force an equity raise, preserving upside if its delayed operating inflection arrives.
NASDAQ
Lifecore Biomedical, INC. \de\
LFCR
1 article
$172M Market cap · 2026-08-21
Investor Letters
Letters that discuss LFCR.
- Laughing Water Capital H1 2026 H1 2026 +33.6% ANAB $1.7BAVNS $1.2BGSK $105BLFCR $172M
- Greenhaven Road Capital Main Fund Q2 Q2 2026 +11.0% BUR $946MCLBT $2.9BHGTY $4.6BANAB $1.7B
- Greenhaven Road Capital Q4 2025 Q4 2025 -2.0% BUR $946MCLBT $2.9BHGTY $4.6BKKR-P-D
- Greenhaven Road Capital Q1 2025 Q1 2025 -12.0% KFS BUR $946MCLBT $2.9BKKR $96B
- Greenhaven Road Capital Q1 2023 first quarter +17.0% BUR $946MAPG $18BBNED $415MCLBT $2.9B
